Voisin-Chiret AS - Search Results

1

Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode.

Hedir S, De Giorgi M, Fogha J, De Pascale M, Weiswald LB, Brotin E, Marekha B, Denoyelle C, Denis C, Suzanne P, Gautier F, Juin P, Ligat L, Lopez F, Carlier L, Legay R, Bureau R, Rault S, Poulain L, Oliveira Santos JS, Voisin-Chiret AS. Hedir S, et al. Eur J Med Chem. 2018 Nov 5;159:357-380. doi: 10.1016/j.ejmech.2018.10.003. Epub 2018 Oct 4. Eur J Med Chem. 2018. PMID: 30308410

2

Synthesis of new L-ascorbic ferulic acid hybrids.

Voisin-Chiret AS, Bazin MA, Lancelot JC, Rault S. Voisin-Chiret AS, et al. Molecules. 2007 Nov 17;12(11):2533-45. doi: 10.3390/12112533. Molecules. 2007. PMID: 18065956 Free PMC article.

3

Efficient and simple synthesis of 6-aryl-1,4-dimethyl-9H-carbazoles.

Caruso A, Voisin-Chiret AS, Lancelot JC, Sinicropi MS, Garofalo A, Rault S. Caruso A, et al. Molecules. 2008 Jun 11;13(6):1312-20. doi: 10.3390/molecules13061312. Molecules. 2008. PMID: 18596657 Free PMC article.

4

Structural characterizations of oligopyridyl foldamers, α-helix mimetics.

Santos JS, Voisin-Chiret AS, Burzicki G, Sebaoun L, Sebban M, Lohier JF, Legay R, Oulyadi H, Bureau R, Rault S. Santos JS, et al. J Chem Inf Model. 2012 Feb 27;52(2):429-39. doi: 10.1021/ci200424a. Epub 2012 Jan 17. J Chem Inf Model. 2012. PMID: 22196240

5

Targeting the BH3 domain of Bcl-2 family proteins. A brief history from natural products to foldamers as promising cancer therapeutic avenues.

De Giorgi M, Voisin-Chiret AS, Rault S. De Giorgi M, et al. Curr Med Chem. 2013;20(24):2964-78. doi: 10.2174/0929867311320240003. Curr Med Chem. 2013. PMID: 23746270 Review.

6

Conformation control of abiotic α-helical foldamers.

Perato S, Fogha J, Sebban M, Voisin-Chiret AS, Sopkova-de Oliveira Santos J, Oulyadi H, Rault S. Perato S, et al. J Chem Inf Model. 2013 Oct 28;53(10):2671-80. doi: 10.1021/ci400365y. Epub 2013 Oct 11. J Chem Inf Model. 2013. PMID: 24032461

7

First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.

Fontaine F, Hequet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S. Fontaine F, et al. J Med Chem. 2014 Mar 27;57(6):2536-48. doi: 10.1021/jm401808n. Epub 2014 Feb 19. J Med Chem. 2014. PMID: 24499135

8

First evidence that oligopyridines, α-helix foldamers, inhibit Mcl-1 and sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies.

Gloaguen C, Voisin-Chiret AS, Sopkova-de Oliveira Santos J, Fogha J, Gautier F, De Giorgi M, Burzicki G, Perato S, Pétigny-Lechartier C, Simonin-Le Jeune K, Brotin E, Goux D, N'Diaye M, Lambert B, Louis MH, Ligat L, Lopez F, Juin P, Bureau R, Rault S, Poulain L. Gloaguen C, et al. J Med Chem. 2015 Feb 26;58(4):1644-68. doi: 10.1021/jm500672y. Epub 2015 Feb 4. J Med Chem. 2015. PMID: 25585174

9

Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.

Fontaine F, Héquet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S. Fontaine F, et al. Eur J Med Chem. 2015 May 5;95:185-98. doi: 10.1016/j.ejmech.2015.02.056. Epub 2015 Mar 2. Eur J Med Chem. 2015. PMID: 25817769

10

Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.

Jouanne M, Rault S, Voisin-Chiret AS. Jouanne M, et al. Eur J Med Chem. 2017 Oct 20;139:153-167. doi: 10.1016/j.ejmech.2017.07.070. Epub 2017 Jul 29. Eur J Med Chem. 2017. PMID: 28800454 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page